BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35070034)

  • 1. Moving forward in the treatment of cholangiocarcinoma.
    Manzia TM; Parente A; Lenci I; Sensi B; Milana M; Gazia C; Signorello A; Angelico R; Grassi G; Tisone G; Baiocchi L
    World J Gastrointest Oncol; 2021 Dec; 13(12):1939-1955. PubMed ID: 35070034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of liver transplantation for cholangiocarcinoma.
    Twohig P; Peeraphatdit TB; Mukherjee S
    World J Gastrointest Surg; 2022 Jan; 14(1):1-11. PubMed ID: 35126858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Saffioti F; Mavroeidis VK
    World J Gastrointest Oncol; 2021 Oct; 13(10):1336-1366. PubMed ID: 34721770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications.
    Panayotova GG; Paterno F; Guarrera JV; Lunsford KE
    Curr Oncol Rep; 2020 Apr; 22(5):49. PubMed ID: 32297105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the management of cholangiocarcinoma.
    Zori AG; Yang D; Draganov PV; Cabrera R
    World J Hepatol; 2021 Sep; 13(9):1003-1018. PubMed ID: 34630871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer review: Cholangiocarcinoma.
    Ghouri YA; Mian I; Blechacz B
    J Carcinog; 2015; 14():1. PubMed ID: 25788866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of liver transplantation for cholangiocarcinoma.
    Goldaracena N; Gorgen A; Sapisochin G
    Liver Transpl; 2018 Feb; 24(2):294-303. PubMed ID: 29024405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma in the Era of Immunotherapy.
    Manthopoulou E; Ramai D; Dhar J; Samanta J; Ioannou A; Lusina E; Sacco R; Facciorusso A
    Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation, diagnosis and staging of cholangiocarcinoma.
    Forner A; Vidili G; Rengo M; Bujanda L; Ponz-Sarvisé M; Lamarca A
    Liver Int; 2019 May; 39 Suppl 1():98-107. PubMed ID: 30831002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.
    Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma: the role of genetic and epigenetic factors; current and prospective treatment with checkpoint inhibitors and immunotherapy.
    Sarantis P; Tzanetatou ED; Ioakeimidou E; Vallilas C; Androutsakos T; Damaskos C; Garmpis N; Garmpi A; Papavassiliou AG; Karamouzis MV
    Am J Transl Res; 2021; 13(12):13246-13260. PubMed ID: 35035673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.
    Bragazzi MC; Ridola L; Safarikia S; Matteo SD; Costantini D; Nevi L; Cardinale V
    Ann Gastroenterol; 2018; 31(1):42-55. PubMed ID: 29333066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.
    Chong DQ; Zhu AX
    Oncotarget; 2016 Jul; 7(29):46750-46767. PubMed ID: 27102149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma.
    Sarcognato S; Sacchi D; Fassan M; Fabris L; Cadamuro M; Zanus G; Cataldo I; Capelli P; Baciorri F; Cacciatore M; Guido M
    Pathologica; 2021 Jun; 113(3):158-169. PubMed ID: 34294934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.
    Lee JJ; Schindera ST; Jang HJ; Fung S; Kim TK
    Abdom Radiol (NY); 2017 Dec; 42(12):2898-2908. PubMed ID: 28951947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma--current treatment options.
    Friman S
    Scand J Surg; 2011; 100(1):30-4. PubMed ID: 21491796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.
    Macias RI
    ISRN Hepatol; 2014; 2014():828074. PubMed ID: 27335842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.